RN

Raja Namakkal Kandasamy

Active Director Managing Director DIN 10524055
DIN 10524055 First appointment Feb 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Raja Namakkal Kandasamy

Data last updated:

Raja Namakkal Kandasamy is a Managing Director at Aionios Pharma Private Limited (since 2024). The company operates in Pharma.

DIN 10524055
Primary Designation Managing Director
Industry Pharma
First Appointment 26 Feb 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aionios Pharma Private Limited U46497KA2024PTC185375
Managing Director26 Feb 20242024Active

Board colleagues of Raja Namakkal Kandasamy

Directorship timeline

Open interactive timeline →
Aionios Pharma Private Limited
Premium access

Shareholding and investment profile for Raja Namakkal Kandasamy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raja Namakkal Kandasamy

Raja Namakkal Kandasamy currently holds 1 directorship: Aionios Pharma Private Limited (Managing Director, since 26 Feb 2024).

Raja Namakkal Kandasamy was first appointed on 26 Feb 2024 as Managing Director at Aionios Pharma Private Limited.

The current boards of Raja Namakkal Kandasamy's companies include Namakkal Kandasamy Sathiyamoorthy (Aionios Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available